HALO vs PG · P/E 15, rev $857.7M vs P/E 25, rev $87.03B
Halozyme Therapeutics Inc (HALO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported PG revenue for 2026-06-30 was $87.03B. Net income was $16.05B. Revenue was up 3.3% from 2025-06-30 to 2026-06-30. PG currently screens at market cap $373.53B and trailing P/E 25.3.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the HALO and PG stock pages for the full models.
Not investment advice.